Shares of Lonza Group Ag (OTCMKTS:LZAGY – Get Free Report) hit a new 52-week high during trading on Wednesday. The company traded as high as $81.49 and last traded at $81.48, with a volume of 4,752 shares traded. The stock had previously closed at $79.31.
Lonza Group Trading Up 0.6%
The firm’s fifty day simple moving average is $71.28 and its two-hundred day simple moving average is $67.42. The company has a quick ratio of 1.21, a current ratio of 1.66 and a debt-to-equity ratio of 0.42.
Lonza Group Company Profile
Lonza Group AG is a Swiss contract development and manufacturing organization (CDMO) that supports pharmaceutical and biotechnology companies throughout the life cycle of their products. The company provides research, process development, testing, manufacturing, and regulatory support for therapies and other healthcare products, helping customers advance programs from early development through commercial production.
Lonza’s activities include the development and manufacture of biologics, small-molecule medicines, and cell and gene therapies.
Recommended Stories
- Five stocks we like better than Lonza Group
- These 3 Underperforming Stocks Are Seeing Notable CEO Insider Trades
- GE Aerospace Has a $170 Billion Backlog, But Is the Stock Worth the Premium?
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.
